Finance

Beta
Lists
OSE:EPA
Ose Immunotherapeutics SA
€3.69
-0.16%
(-0.0060) 1D
Jun 5, 5:35:11 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OSE...
Open
€3.72
High
€3.92
Low
€3.69
Mkt. cap
83.69M
Avg. vol.
408.42K
Volume
271.80K
52-wk high
€7.70
52-wk low
€2.87
EPS
-€1.69
Shares outstanding
22.68M
No. of employees
64
Open
€3.72
High
€3.92
Low
€3.69
Mkt. cap
83.69M
Avg. vol.
408.42K
Volume
271.80K
52-wk high
€7.70
52-wk low
€2.87
EPS
-€1.69
Shares outstanding
22.68M
No. of employees
64
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to OSE in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for OSE in the last 3 months.
Highest
Current €3.69
€8.20 (+121.98%)
Average
€8.20 (+121.98%)
Lowest
€8.20 (+121.98%)
News stories
From sources across the web
About Ose Immunotherapeutics SA
CEO-
Employees64
FoundedNov 17, 2004
Headquarters-
SectorBiotechnology
Websiteose-immuno.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Revenue
41.29M
41.29M
431.00K
431.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.94M
6.94M
8.28M
8.28M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.05M
2.05M
1.08M
1.08M
Operating expense
9.63M
9.63M
10.22M
10.22M
Total operating expenses
9.63M
9.63M
10.22M
10.22M
Operating income
31.66M
31.66M
-9.79M
-9.79M
Other non operating income
-596.00K
-596.00K
-611.00K
-611.00K
EBT including unusual items
30.36M
30.36M
-10.44M
-10.44M
EBT excluding unusual items
30.33M
30.33M
-10.53M
-10.53M
Income tax expense
1.77M
1.77M
-576.50K
-576.50K
Effective tax rate
5.83%
5.83%
5.52%
5.52%
Other operating expenses
94.50K
94.50K
41.00K
41.00K
Net income
28.59M
28.59M
-9.86M
-9.86M
Net profit margin
69.24%
69.24%
-2,288.86%
-2,288.86%
Earnings per share
-
-
-
-
Interest and investment income
162.50K
162.50K
571.00K
571.00K
Interest expense
-878.50K
-878.50K
-707.50K
-707.50K
Net interest expenses
-716.00K
-716.00K
-136.50K
-136.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
31.72M
31.72M
-9.74M
-9.74M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer